Loading
MP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) Stock: price and insider trades · Canada
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.): what insiders have been doing
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) is a listed company. Its directors and officers file their transactions with SEDI. Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) has had no insider filing for more than a year; the last one goes back to 29 September 2025.
Over the whole record (from 2018), the tally stands at 70 purchases and 3 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
226
Thresholds
n/a
Buy Volume
€517,275
70 ops. · all time
Sell Volume
€13,663
3 ops. · all time
Who traded when
BuySaleBrendon Buschman2 buys
Mike Mueller1 buy1 sale
Stephen William Nelson1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 29 September 2025
Declarations226 total
18,457 shares@ CA$2.98100.0% of flowCommon SharesTSXSEDI:4580845
18,457 shares@ CA$2.98100.0% of flowCommon SharesTSXSEDI:4580841
17,804 shares@ CA$2.9887.6% of flowCommon SharesTSXSEDI:4580837
17,980 shares@ CA$2.9892.7% of flowCommon SharesTSXSEDI:4580833
17,894 shares@ CA$2.98100.0% of flowCommon SharesTSXSEDI:4580829
18,457 shares@ CA$2.98100.0% of flowCommon SharesTSXSEDI:4580824
50,222 shares@ CA$2.7584.3% of flowCommon SharesTSXSEDI:4565736
30,000 shares@ CA$2.918759.3% of flowCommon SharesTSXSEDI:4564486
Canonical exit: 18 Nov 2025 (T+90)
5,000 shares@ CA$3.0730.8% of flowCommon SharesTSXSEDI:4451632
Canonical exit: 11 May 2025 (T+90)
10,000 shares@ CA$3.4769.2% of flowCommon SharesTSXSEDI:4451631
Canonical exit: 8 May 2025 (T+90)
Common SharesTSXSEDI:4415975
3,500 shares@ CA$2.864.8% of flowCommon SharesTSXSEDI:4415979
3,500 shares@ CA$2.894.9% of flowCommon SharesTSXSEDI:4415982
Canonical exit: 6 Mar 2025 (T+90)
9,074 shares@ CA$2.09Common SharesTSXSEDI:4405200
2,258 shares@ CA$2.09Common SharesTSXSEDI:4405189
4,063 shares@ CA$2.09Common SharesTSXSEDI:4405207
Common SharesTSXSEDI:4380990
7,200 shares@ CA$2.43Common SharesTSXSEDI:4380975
11,153 shares@ CA$2.43Common SharesTSXSEDI:4380995
7,174 shares@ CA$2.43Common SharesTSXSEDI:4380972
11,153 shares@ CA$2.43Common SharesTSXSEDI:4380992
11,153 shares@ CA$2.43Common SharesTSXSEDI:4380970
7,200 shares@ CA$2.43Common SharesTSXSEDI:4380981
3,000 shares@ CA$2.501.9% of flowCommon SharesTSXSEDI:4379103
Canonical exit: 18 Dec 2024 (T+90)
3,600 shares@ CA$2.446Common SharesTSXSEDI:4366399
Canonical exit: 21 Nov 2024 (T+90)
25 of 226 declarations
About Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.)
Medexus Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of specialized pharmaceutical products. Formerly known as Pediapharm Inc., it primarily operates in the Canadian market.
